| 7501/13381 | US=50 / Câncer Wei S, Shreiner AB, Chang AE. Vaccine-primed lymph node cells in the adoptive immune suppression induced by established cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 425-32. ISBN 978-1-60327-086-1. CELULAS T; IMUNOSSUPRESSAO; IMUNOTERAPIA ADOPTIVA; VACINAS; LINFONODOS |
| 7502/13381 | US=50 / Câncer Boonyaratanakornkit JB, Smith JE, Ghadially R. Cancer stem cells in metastatic melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 435-41. ISBN 978-1-60327-086-1. CELULAS-TRONCO CANCEROSAS. MELANOMA METASTATICO; CELULAS-TRONCO DO CANCER; MELANOMA; METASTASE |
| 7503/13381 | US=50 / Câncer Kalani MA, Dalerge P, Clarke MF. Implications of cancer stem cells for tumor metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 443-53. ISBN 978-1-60327-086-1. IMPLICACOES DE CELULAS-TRONCO DO CANCER; METASTASE DE TUMOR; CELULAS-TRONCO DO CANCER; PROGNOSTICO DO PACIENTE; SOBREVIDA LIVRE DE METASTASES; MICROARRAY PERFIL DE EXPRESSAO GENICA; IMUNO-HISTOQUIMICA |
| 7504/13381 | US=50 / Câncer Li H, Tang DG. Prostate cancer stem cells and their involvement in metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 455-61. ISBN 978-1-60327-086-1. CANCER DE PROSTATA. CELULAS-TRONCO; CANCER DE PROSTATA; CELULAS-TRONCO DO CANCER; TUMORAIS CELULAS PROGENITORAS; METASTASE; CELULAS ESTAMINAIS METASTATICO |
| 7505/13381 | US=50 / Câncer Baehner FL. Estrogen receptor-positive breast cancer: tradicional prognostics, molecular pathology: a new breast cancer taxonomy and 21st century personalized prognostic and predictive assays. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 465-95. ISBN 978-1-60327-086-1. PERFIL DE EXPRESSAO DE GENE; QRT-PCR; CANCER DE MAMA; CANCER DE MAMA TIPO BASAL; CANCER DA MAMA HER2 TIPO; CANCER DE MAMA TIPO LUMINAL; PROGNOSTICO; PREDITIVO |
| 7506/13381 | US=50 / Câncer Venna SS, Kashani-Sabet M. Molecular signatures in melanoma progression. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1. ASSINATURAS MOLECULARES EM PROGRESSAO MELANOMA; EXPRESSAO DO GENE; MARCADORES MOLECULARES; MELANOMAS FINOS; LINFONODO SENTINELA; METASTASE; FASE DE CRESCIMENTO RADIAL; FASE DE CRESCIMENTO VERTICAL |
| 7507/13381 | US=50 / Câncer Rugo HS, Lin AYJ. Targeted therapy for breast cancer: a focus on HER2/neu and antiangiogenic therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1. TERAPIA-ALVO PARA CANCER DE MAMA; HER2/NEU E TERAPIA ANTIANGIOGENICA; CANCER DE MAMA METASTATICO; HER2/NEU; TRASTUZUMAB; LAPATINIB; BEVACIZUMAB; SUNITINIB; ANTIANGIOGENICO; TERAPIA-ALVO |
| 7508/13381 | US=60 / Biol/Mol Karna P, Yang L. Apoptotic signaling pathway and resistance to apoptosis in breast cancer stem cells. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 1-23. ISBN 978-1-4020-9596-2. RESISTENCIA A APOPTOSE; CELULAS TRONCO EM NEOPLASIAS DE MAMA; TERAPIA DE ALVO MOLECULAR; VIA APOPTOTICA; MECANISMOS DE RESISTENCIA A APOPTOSE |
| 7509/13381 | US=50 / Câncer Ma WW, Jimeno A, Choti MA. Advances in the treatment of colorectal cancertargeting receptors of disease. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 523-32. ISBN 978-1-60327-086-1. TRATAMENTO DO CANCER COLORECTAL; RECEPTORES DE SEGMENTACAO DE DOENCA; CANCER COLORRETAL; BEVACIZUMAB; CETUXIMAB; PANITUMUMAB; KRAS |
| 7510/13381 | US=50 / Câncer Ryan CJ. Development in the management of genitourinary malignancies: prostate cancer and renal cell carcinoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 533-44. ISBN 978-1-60327-086-1. DOENCAS MALIGNAS DO APARELHO GENITURINARIO; CANCER DE PROSTATA; CARCINOMA DE CELULAS RENAIS; CASTRACAO-RESISTENTE O CANCER DE PROSTATA; ANDROGENIOS ADRENAIS; IMUNOTERAPIA; FASE II; ABIRATERONA; ATRASENTAN; BEVACIZUMAB; CALCITRIOL; QUIMIOTERAPIA; GVAX; IPILIMUMAB; IXABEPILONA; SATRAPLATIN; SIPULEUCEL-T; VEGF; SUNITINIB; SORAFENIB |
| 7511/13381 | US=50 / Câncer Karrim J, Dubey S. Advances in the treatment of lung cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 545-52. ISBN 978-1-60327-086-1. TRATAMENTO DO CANCER DO PULMAO; NEOPLASIAS PULMONARES; QUIMIOTERAPIA; ADJUVANTE; MARCADORES BIOLOGICOS; ANGIOGENESE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DA PROTEINA QUINASE; ANTICORPOS MONOCLONAIS; RADIOTERAPIA |
| 7512/13381 | US=60 / Biol/Mol Karam JA, Hsieh JT. Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 25-50. ISBN 978-1-4020-9596-2. APOPTOSE; AUTOFAGIA; CANCER DE BEXIGA; NECROSE; MORTE CELULAR PROGRAMADA; VIAS DE SINALIZACAO |
| 7513/13381 | US=60 / Biol/Mol Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV) |
| 7514/13381 | US=50 / Câncer Schadendorf D. Pegylated interferons in the adjuvant treatment of melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 555-64. ISBN 978-1-60327-086-1. TRATAMENTO ADJUVANTE DO MELANOMA. INTERFERON PEGUILADO; INTERFERON PEGUILADO; SOBREVIDA LIVRE DE RECIDIVA; SOBREVIDA GLOBAL; MELANOMA; EFEITOS IFN; AJCC ESTAGIO III |
| 7515/13381 | US=60 / Biol/Mol Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA |
| 7516/13381 | US=50 / Câncer Hauschild A, Kahler KC, Egberts F. Sorafenib, a multikinase inhibitor: results from clinical trials in melanoma patients. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 565-74. ISBN 978-1-60327-086-1. SORAFENIB. INIBIDOR MULTIQUINASE; PACIENTES COM MELANOMA; MELANOMA; METASTASE; SORAFENIB; INIBIDORES MULTIQUINASE |
| 7517/13381 | US=50 / Câncer Chmielowski B, Ribas A. Targeting immunological synapse: new horizons in immunotherapy for cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 575-90. ISBN 978-1-60327-086-1. SEGMENTACAO SINAPSE IMUNOLOGICA; IMUNOTERAPIA PARA O CANCER; IMUNOTERAPIA; SINAPSE IMUNOLOGICA; CTLA-4; AUTO-IMUNIDADE; MELANOMA; CANCER |
| 7518/13381 | US=50 / Câncer Garbe C, Weide B, Pflugfelder A, Eigentler T. Cutaneous metastases of melanoma: new treatment options. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 591-8. ISBN 978-1-60327-086-1. METASTASES CUTANEAS DE MELANOMA. TRATAMENTO; MELANOMA; METASTASES CUTANEAS; INTERLEUCINA-2; IMIQUIMOD; BLEOMYCINE; TRATAMENTO INTRATUMORAL |
| 7519/13381 | US=50 / Câncer Tarhini AA, Kirkwood JM. Neoadjuvant approaches in melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 599-605. ISBN 978-1-60327-086-1. NEO-ADJUVANTE EM MELANOMA; MELANOMA; NEOADJUVANTE; INTERFERON; IMUNOTERAPIA |
| 7520/13381 | US=50 / Câncer Agarwala SS. Implications of chemo/biochemotherapy in the treatment of metastatic melanoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 607-9. ISBN 978-1-60327-086-1. QUIMIO/BIOQUIMIOTERAPIA. TRATAMENTO DO MELANOMA; IMUNOTERAPIA; QUIMIOTERAPIA; BIOQUIMIOTERAPIA; MELANOMA METASTATICO |